跳转至内容
Merck
CN

160415

3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪

≥99%

别名:

5,6-二苯基-3-(2-吡啶基)-1,2,4-三嗪, PDT

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C20H14N4
化学文摘社编号:
分子量:
310.35
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
213-878-7
Beilstein/REAXYS Number:
542151
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪, ≥99%

InChI

1S/C20H14N4/c1-3-9-15(10-4-1)18-19(16-11-5-2-6-12-16)23-24-20(22-18)17-13-7-8-14-21-17/h1-14H

InChI key

OTMYLOBWDNFTLO-UHFFFAOYSA-N

SMILES string

c1ccc(cc1)-c2nnc(nc2-c3ccccc3)-c4ccccn4

assay

≥99%

mp

191-193 °C (lit.)

functional group

phenyl

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

在分光光度法测定酸和酸性溶液中的铁的过程中,使用3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪作为显色提取试剂。 它也被用作HPLC方法中的柱前衍生试剂,从而通过UV吸光度对Fe(II)进行测定。

General description

3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪(PDT)与高氯酸铜(II)在乙醇中反应,可生成[Cu(PDT)2(CLO42]。

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yvonne H W Derks et al.
Theranostics, 11(4), 1527-1541 (2021-01-08)
Incomplete resection of prostate cancer (PCa) occurs in 15%-50% of PCa patients. Disease recurrence negatively impacts oncological outcome. The use of radio-, fluorescent-, or photosensitizer-labeled ligands to target the prostate-specific membrane antigen (PSMA) has become a well-established method for the
Yu-Cherng Channing Chang et al.
Scientific reports, 7(1), 9746-9746 (2017-08-31)
Tumor heterogeneity can be elucidated by mapping subregions of the lesion with differential imaging characteristics, called habitats. Dynamic Contrast Enhanced (DCE-)MRI can depict the tumor microenvironments by identifying areas with variable perfusion and vascular permeability, since individual tumor habitats vary
Sungsoon Hwang et al.
Retina (Philadelphia, Pa.), 39(6), 1117-1124 (2018-03-09)
To report the clinical outcomes of reduced-fluence photodynamic therapy (PDT) for symptomatic subfoveal retinal pigment epithelial detachment (RPED) in central serous chorioretinopathy and identify prognostic factors affecting treatment outcome. This retrospective interventional study included 35 eyes of 35 patients with
Thomas J van Rijssen et al.
PloS one, 13(8), e0202549-e0202549 (2018-08-25)
To assess parameters on optical coherence tomography (OCT), and their correlation with best-corrected visual acuity (BCVA) in patients with non-resolving central serous chorioretinopathy (CSC). For 25 non-resolving CSC patients treated with photodynamic therapy (PDT), the thickness of retinal layers was
Nathalia Ramos da Silva et al.
Lasers in medical science, 32(6), 1253-1260 (2017-05-17)
Photodynamic therapy (PDT) is a promising treatment for oral candidoses. Its use as an alternative to antifungals prevents several adverse effects, including microbial resistance. However, most PDT protocols do not employ devices and consumables commonly available in dental practice, thus

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持